Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 4;25(1):453.
doi: 10.1186/s13063-024-08229-z.

A multi-centric, single-blinded, randomized, parallel-group study to evaluate the effectiveness of nasoalveolar moulding treatment in non-syndromic patients with complete unilateral cleft lip, alveolus and palate (NAMUC study): a study protocol for a randomized controlled trial

Affiliations

A multi-centric, single-blinded, randomized, parallel-group study to evaluate the effectiveness of nasoalveolar moulding treatment in non-syndromic patients with complete unilateral cleft lip, alveolus and palate (NAMUC study): a study protocol for a randomized controlled trial

Badri Thiruvenkatachari et al. Trials. .

Abstract

Background: Cleft lip and palate (CLP) are among the most common congenital anomaly that affects up to 33,000 newborns in India every year. Nasoalveolar moulding (NAM) is a non-surgical treatment performed between 0 and 6 months of age to reduce the cleft and improve nasal aesthetics prior to lip surgery. The NAM treatment has been a controversial treatment option with 51% of the cleft teams in Europe, 37% of teams in the USA and 25 of cleft teams in India adopting this methodology. This treatment adds to the already existing high burden of care for these patients. Furthermore, the supporting evidence for this technique is limited with no high-quality long-term clinical trials available on the effectiveness of this treatment.

Method: The NAMUC study is an investigator-initiated, multi-centre, single-blinded randomized controlled trial with a parallel group design. The study will compare the effectiveness of NAM treatment provided prior to lip surgery against the no-treatment control group in 274 patients with non-syndromic unilateral complete cleft lip and palate. The primary endpoint of the trial is the nasolabial aesthetics measured using the Asher McDade index at 5 years of age. The secondary outcomes include dentofacial development, speech, hearing, cost-effectiveness, quality of life, patient perception, feeding and intangible benefits. Randomization will be carried out via central online system and stratified based on cleft width, birth weight and clinical trial site.

Discussion: We expect the results from this study on the effectiveness of treatment with NAM appliance in the long term along with the cost-effectiveness evaluation can eliminate the dilemma and differences in clinical care across the globe.

Trial registration: ClinicalTrials.gov CTRI/2022/11/047426 (Clinical Trials Registry India). Registered on 18 November 2022. The first patient was recruited on 11 December 2022. CTR India does not pick up on Google search with just the trial number. The following steps have to be carried out to pick up. How to search: ( https://ctri.nic.in/Clinicaltrials/advsearch.php -use the search boxes by entering the following details: Interventional trial > November 2022 > NAMUC).

Keywords: CLP; Cleft lip and palate; NAM treatment; Nasoalveolar moulding; PSIO; Presurgical infant orthopaedics; Randomized controlled trials.

PubMed Disclaimer

Conflict of interest statement

None of the authors or study members have any conflicts of interest. Dr. Pedro Santiago and Dr. Barry Grayson conduct courses to promote the NAM technique but do not receive any other financial benefits. Both clinicians will be involved in the calibration exercise and in training the study investigators on the clinical treatment protocol. However, they will not be involved in the study’s methodology, execution or dissemination.

Figures

Fig. 1
Fig. 1
Schematics of trial design
Fig. 2
Fig. 2
Nasoalveolar moulding appliance in situ with a nasal stent to lift the cleft-sided nostril upward and forward
Fig. 3
Fig. 3
SPIRIT figure
Fig. 4
Fig. 4
The schedule of eligibility screening, enrollment, group allocation, visits, interventions and assessments
Fig. 5
Fig. 5
Flowchart for adverse event reporting

Similar articles

References

    1. Vanderas AP. Incidence of cleft lip, cleft palate, and cleft lip and palate among races: a review. Cleft Palate J. 1987;24(3):216–225. - PubMed
    1. Mossey P, Little J. Addressing the challenges of cleft lip and palate research in India. Indian J Plast Surg. 2009;42(Suppl):S9–S18. doi: 10.4103/0970-0358.57182. - DOI - PMC - PubMed
    1. Grayson BH, Santiago PE, Brecht LE, Cutting CB. Presurgical nasoalveolar molding in infants with cleft lip and palate. Cleft Palate Craniofac J. 1999;36:486–498. doi: 10.1597/1545-1569_1999_036_0486_pnmiiw_2.3.co_2. - DOI - PubMed
    1. Barillas I, Dec W, Warren SM, Cutting CB, Grayson BH. Nasoalveolar molding improves long-term nasal symmetry in complete unilateral cleft lip-cleft palate patients. Plast Reconstr Surg. 2009;123:1002–1006. doi: 10.1097/PRS.0b013e318199f46e. - DOI - PubMed
    1. Ezzat CF, Chavarria C, Teichgraeber JF, Chen JW, Stratmann RG, Gateno J, Xia JJ. Presurgical nasoalveolar molding therapy for the treatment of unilateral cleft lip and palate: a preliminary study. Cleft Palate Craniofac J. 2007;44:8–12. doi: 10.1597/06-009. - DOI - PubMed

Publication types